214 results on '"MALYSZKO, JACEK S"'
Search Results
2. Green dialysis – let us talk about dialysis fluid.
3. Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant
4. Lack or insufficient predialysis nephrology care worsens the outcomes in dialyzed patients – call for action
5. Cognitive Impairment and Kidney Transplantation: Underestimated, Underrecognized but Clinically Relevant Problem
6. The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years
7. Thyroid Function, Endothelium, and Inflammation in Hemodialyzed Patients: Possible Relations?
8. Fluvastin therapy affects TAFI concentration in kidney transplant recipients
9. Renalase, Hypertension, and Kidney — The Discussion Continues
10. Labile plasma iron levels in chronic hemodialysis patients treated by intravenous iron supplementation
11. Visfatin and endothelial function in dialyzed patients
12. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients
13. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
14. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease
15. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients
16. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography
17. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention
18. Hepcidin, Iron Status, and Renal Function in Chronic Renal Failure, Kidney Transplantation, and Hemodialysis
19. Estimation of glomerular filtration rate in patients with normal serum creatinine undergoing primary PCI: is it really normal?
20. Renal transplant recipients with coronary artery disease exhibit impairment in fibrinolysis and structural changes in carotid arteries
21. Adiponectin Is Related to CD146, a Novel Marker of Endothelial Cell Activation/Injury in Chronic Renal Failure and Peritoneally Dialyzed Patients
22. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients
23. Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
24. Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
25. Labile plasma iron levels in chronic hemodialysis patients treated by intravenous iron supplementation.
26. The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance
27. Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?
28. The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance.
29. Emerging drugs for the treatment of kidney disease-induced anemia
30. Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient
31. Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?
32. Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient.
33. FP797ENDOCAN SERUM LEVELS IN HEMODIALYSIS PATIENTS BEFORE AND DURING THE PROCEDURE WITH TWO DIFFERENT DIALYSIS MEMBRANES
34. Midkine: A Novel and Early Biomarker of Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions
35. Letter to the Editor Chronic kidney disease in patients with significant left main coronary artery disease qualified for coronary artery bypass graft operation
36. Iron metabolism in hemodialyzed patients – a story half told?
37. GDF15 Is Related to Anemia and Hepcidin in Kidney Allograft Recipients
38. Renalase, Hypertension, and Kidney — The Discussion Continues
39. Renalase, Stroke, and Hypertension in Hemodialyzed Patients
40. Hypertension and kidney disease
41. VAP-1, a Novel Molecule Linked to Endothelial Damage and Kidney Function in Kidney Allograft Recipients
42. Renalase, a Novel Enzyme Involved in Blood Pressure Regulation, Is Related to Kidney Function but Not to Blood Pressure in Hemodialysis Patients
43. Copeptin and Its Relation to Arteriovenous Fistula (AVF) Type and NYHA Class in Hemodialysis Patients
44. Perfusion defects on real-time myocardial contrast echocardiography predict higher mortality in patients with end-stage renal disease – A 3-year follow-up
45. Possible Relationship between Neutrophil Gelatinase-Associated Lipocalin, Hepcidin, and Inflammation in Haemodialysed Patients
46. Urinary and Serum Biomarkers after Cardiac Catheterization in Diabetic Patients with Stable Angina and without Severe Chronic Kidney Disease
47. Type of Renal Replacement Therapy and Residual Renal Function May Affect Prohepcidin and Hepcidin
48. Neutrophil Gelatinase-Associated Lipocalin in Dialyzed Patients Is Related to Residual Renal Function, Type of Renal Replacement Therapy and Inflammation
49. Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Patients with Chronic Heart Failure and Coronary Artery Disease
50. Hyporesponsiveness to Erythropoietin Therapy in Hemodialyzed Patients: Potential Role of Prohepcidin, Hepcidin, and Inflammation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.